Vaxart, Inc.

VXRT ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $35.2M

Liabilities Breakdown FY2018

Total Liabilities: $24.0M